PMID: 9533729Apr 9, 1998Paper

Introduction and clonal spread of penicillin- and trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae, serotype 9V, in southern Sweden

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
E MelanderS Mölstad

Abstract

As part of an intervention project, all patients in Malmöhus county with a culture positive for penicillin-resistant pneumococci, MIC > or =0.5 mg/L (PRP), have been registered since January 1995. Nasopharyngeal specimens were obtained from family members and close contacts of identified carriers. Children were denied attendance at regular day-care until PRP-negative. In 1995 and 1996, PRP were isolated from 882 individuals, 364 of whom had clinical infection and the remaining of whom were asymptomatic carriers. In 49%, the PRP were of serogroup 9, with MIC of penicillin 0.5-2.0 mg/L and resistance to trimethoprim/sulfamethoxazole. Further analyses with serotyping and genetic fingerprinting suggested strongly that most of the isolates belonged to a single serotype 9V clone. Month by month, an apparently continuous spread appeared from one municipality to a neighboring one. In most communities, the serotype 9V PRP appeared and disappeared within a few months. The active procedures of the intervention project may have limited the spread of the clone in the county.

References

Oct 1, 1992·The Pediatric Infectious Disease Journal·M G DoyleL K Pickering
Dec 1, 1992·The Journal of Infectious Diseases·M R ReichlerR O Walton
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P C Appelbaum
Aug 1, 1991·The Journal of Infectious Diseases·R MuñozB G Spratt
Aug 1, 1990·American Journal of Diseases of Children·A M RauchL K Pickering
Jun 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J C LefèvreG Faucon
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·K Ekdahl, C Kamme
Feb 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K P KlugmanB G Spratt
Mar 1, 1994·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Forsgren, M Walder
May 1, 1996·Journal of Clinical Microbiology·A van BelkumP W Hermans

❮ Previous
Next ❯

Citations

Mar 27, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Lipsitch
Oct 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vilhjalmur A ArasonKarl G Kristinsson
Jul 3, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·K EkdahlK Persson
Sep 28, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Patricia GeliKarl Ekdahl
Jan 6, 2001·The Pediatric Infectious Disease Journal·E MelanderS Mölstad
Jun 23, 2004·Emerging Infectious Diseases·Eva MelanderHåkan Ringberg
Jun 12, 2008·Wiener klinische Wochenschrift·Johan Struwe
Jul 27, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sigurdur E Vilhelmsson, Karl G Kristinsson
Mar 1, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Karl Ekdahl, Otto Cars
Jan 26, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M TsoliaT Karpathios
May 20, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·C KammeS Mölstad
Feb 22, 2001·Journal of Travel Medicine·H J KoornhofL McGee
Nov 11, 1999·Scandinavian Journal of Primary Health Care·E MelanderS Mölstad
Sep 30, 2006·Scandinavian Journal of Infectious Diseases·Percy Nilsson, Martin H Laurell
Feb 24, 2001·Acta Paediatrica. Supplement·M ErikssonK Ekdahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
C KammeS Mölstad
Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Karl G Kristinsson
© 2022 Meta ULC. All rights reserved